Pilzsinusitis

 

 Buy Article Permissions and Reprints

Zusammenfassung

Die Häufigkeit von Pilzsinusitiden unterliegt erheblichen geografischen Unterschieden. Grundsätzlich werden invasive Formen von nicht-invasiven Formen unterscheiden. Invasive Pilzsinusitiden werden vor allem bei immunsupprimierten Patienten beobachtet. Zur Diagnostik ist neben dem Pilznachweis ein pilztypisches klinisches Bild erforderlich. Die Behandlung invasiver Pilzsinusitiden beruht auf chirurgischem Debridement und systemischer antimykotischer Therapie. Nicht-invasive Pilzsinusitiden werden entweder allein chirurgisch oder chirurgisch in Kombination mit einer systemischen Steroidtherapie behandelt. Die Mehrzahl der Untersuchungen zeigte keinen Vorteil einer postoperativen fungostatischen Therapie bei nicht-invasiver Pilzsinusitis.

Abstract

The incidence of fungal sinusitis is subjected to significant geographical variation. Basically, invasive and non-invasive fungal sinusitis is distinguished. Invasive fungal sinusitis is observed mainly in immunocompromised hosts. The diagnopsis is based on positive fungus detection combined with characteristic clinical features. The treatment of invasive fungal sinusitis is based on surgical debridement and systemic antifungal therapy. Non-invasive fungal sinusitis is either treated with surgery alone or surgery combined with systemic steroid therapy. The majority of studies showed no benefit of postoperative antimycotic medical treatment in patients with non-invasive fungal sinusitis.

Literatur

• 1 Shelton BG, Kirkland KH, Flanders WD, Morris GK. Profiles of airborne fungi in buildings and outdoor environments in the United States.  Appl Environ Microbiol. 2002;  68 1743-1753
  Google Scholar
• 2 Green BJ, Tovey ER, Sercombe JK, Beezhold DH, Schmechel D. Airborne fungal fragments and allergenicity.  Med Mycol. 2006;  44 (Suppl. 1) S245-S255
  Google Scholar
• 3 Ferguson BJ. Definitions of fungal rhinosinusitis.  Otolaryngol Clin North Am. 2000;  33 227-235
  Google Scholar
• 4 Chakrabarti A, Denning DW, Ferguson BJ, Ponikau J, Buzina W, Kita H. et al . Fungal rhinosinusitis: a categorization and definitional schema addressing current controversies.  Laryngoscope. 2009;  119 1809-1818
  Google Scholar
• 5 Das A, Bal A, Chakrabarti A, Joshi K. Spectrum of fungal rhinosinusitis; histopathologist's perspective.  Histopathology. 2009;  54 854-859
  Google Scholar
• 6 Bent III JP, Kuhn FA. Diagnosis of allergic fungal sinusitis.  Otolaryngol Head Neck Surg. 1994;  111 580-588
  Google Scholar
• 7 Ferguson BJ. Categorization of eosinophilic chronic rhinosinusitis.  Curr Opin Otolaryngol Head Neck Surg. 2004;  12 237-242
  Google Scholar
• 8 Polzehl D, Weschta M, Podbielski A, Riechelmann H, Rimek D. Fungus culture and PCR in nasal lavage samples of patients with chronic rhinosinusitis.  J Med Microbiol. 2005;  54 31-37
  Google Scholar
• 9 Ponikau JU, Sherris DA, Kern EB, Homburger HA, Frigas E, Gaffey TA. et al . The diagnosis and incidence of allergic fungal sinusitis.  Mayo Clin Proc. 1999;  74 877-884
  Google Scholar
• 10 Nagano Y, Elborn JS, Millar BC, Walker JM, Goldsmith CE, Rendall J. Comparison of techniques to examine the diversity of fungi in adult patients with cystic fibrosis.  Med Mycol. 2010;  48 166-176
  Google Scholar
• 11 Lara JF, Gomez JD. Allergic mucin with and without fungus: a comparative clinicopathologic analysis.  Arch Pathol Lab Med. 2001;  125 1442-1447
  Google Scholar
• 12 Ferguson BJ. Eosinophilic mucin rhinosinusitis: a distinct clinicopathological entity.  Laryngoscope. 2000;  110 799-813
  Google Scholar
• 13 Pant H, Kette FE, Smith WB, Macardle PJ, Wormald PJ. Eosinophilic mucus chronic rhinosinusitis: clinical subgroups or a homogeneous pathogenic entity?.  Laryngoscope. 2006;  116 1241-1247
  Google Scholar
• 14 Ebbens FA, Georgalas C, Fokkens WJ. Fungus as the cause of chronic rhinosinusitis: the case remains unproven.  Curr Opin Otolaryngol Head Neck Surg. 2009;  17 43-49
  Google Scholar
• 15 Reddy CE, Gupta AK, Singh P, Mann SB. Imaging of granulomatous and chronic invasive fungal sinusitis: comparison with allergic fungal sinusitis.  Otolaryngol Head Neck Surg. 2010;  143 294-300
  Google Scholar
• 16 Broglie MA, Tinguely M, Holzman D. How to diagnose sinus fungus balls in the paranasal sinus? An analysis of an institution's cases from January 1999 to December 2006.  Rhinology. 2009;  47 379-384
  Google Scholar
• 17 Wise SK, Rogers GA, Ghegan MD, Harvey RJ, DelGaudio JM, Schlosser RJ. Radiologic staging system for allergic fungal rhinosinusitis (AFRS).  Otolaryngol Head Neck Surg. 2009;  140 735-740
  Google Scholar
• 18 Wiley JM, Seibel NL, Walsh TJ. Efficacy and safety of amphotericin B lipid complex in 548 children and adolescents with invasive fungal infections.  Pediatr Infect Dis J. 2005;  24 167-174
  Google Scholar
• 19 Hachem RY, Boktour MR, Hanna HA, Husni R, Hanna EY, Keutgen X. et al . Sinus surgery combined with antifungal therapy is effective in the treatment of invasive Aspergillus sinusitis in neutropenic patients with cancer.  Infection. 2008;  36 539-542
  Google Scholar
• 20 Thursky KA, Playford EG, Seymour JF, Sorrell TC, Ellis DH, Guy SD. et al . Recommendations for the treatment of established fungal infections.  Intern Med J. 2008;  38 496-520
  Google Scholar
• 21 Ringden O, Labopin M, Gorin NC, Le Blanc K, Rocha V, Gluckman E. Treatment with granulocyte colony-stimulating factor after allogeneic bone marrow transplantation for acute leukemia increases the risk of graft-versus-host disease and death: a study from the Acute Leukemia Working Party of the European Group for Blood and Marrow Transplantation.  J Clin Oncol. 2004;  22 416-423
  Google Scholar
• 22 Stanworth SJ, Massey E, Hyde C, Brunskill S, Lucas G, Navarrete C. et al . Granulocyte transfusions for treating infections in patients with neutropenia or neutrophil dysfunction.  Cochrane Database Syst Rev. 2005;  3 CD005339
  Google Scholar
• 23 Walsh TJ, Anaissie EJ, Denning DW. Treatment of aspergillosis: clinical practice guidelines of the Infectious Diseases Society of America.  Clin Infect Dis. 2008;  46 327-360
  Google Scholar
• 24 Dufour X, Kauffmann-Lacroix C, Ferrie JC, Goujon JM, Rodier MH, Klossek JM. Paranasal sinus fungus ball: epidemiology, clinical features and diagnosis. A retrospective analysis of 173 cases from a single medical center in France, 1989–2002.  Med Mycol. 2006;  44 61-67
  Google Scholar
• 25 Rupa V, Jacob M, Mathews MS, Seshadri MS. A prospective, randomised, placebo-controlled trial of postoperative oral steroid in allergic fungal sinusitis.  Eur Arch Otorhinolaryngol. 2010;  267 233-238
  Google Scholar
• 26 Fokkens W, Lund V, Mullol J. et al . European Position Paper on Rhinosinusitis and Nasal Polyps.  Rhinology. 2007;  45 (Suppl. 20) 1-139
  Google Scholar
• 27 Seiberling K, Wormald PJ. The role of itraconazole in recalcitrant fungal sinusitis.  Am J Rhinol Allergy. 2009;  23 303-306
  Google Scholar
• 28 Weschta M, Rimek D, Formanek M, Polzehl D, Podbielski A, Riechelmann H. Topical antifungal treatment of chronic rhinosinusitis with nasal polyps: a randomized, double-blind clinical trial J Allergy Clin Immunol.  2004;  113 (6) 1122-1128
  Google Scholar
• 29 Ebbens FA, Georgalas C, Rinia AB, van Drunen CM, Lund VJ, Fokkens WJ. The fungal debate: where do we stand today?.  Rhinology. 2007;  45 178-189
  Google Scholar
• 30 Mabry RL, Mabry CS. Allergic fungal sinusitis: the role of immunotherapy.  Otolaryngol Clin North Am. 2000;  33 433-440
  Google Scholar

1 Muzine sind eine Familie stark glykosylierter Proteine (Glykokonjugate) mit hohem Molekulargewicht. Muzine kommen in unterschiedlichen Körperflüssigkeiten einschließlich der Muttermilch vor. Das Proteingerüst wird von einer Gruppe von etwa 20 Genen kodiert (MUC-Gene).

2 Normalwerte Gesamt-IgE: <100 IU/ml (<300 ng/ml) bei Erwachsenen, <60 IU/ml bei Kindern <200 IU/ml bei Adoleszenten.

Korrespondenzadresse

Prof. Herbert Riechelmann

Univ. HNO-Klinik Innsbruck

Anichstraße 35

A–6020 Innsbruck

Österreich

Email: Herbert.RIECHELMANN@uki.at